High Volume Injection or Autologous Conditioned Plasma (ACP) in Chronic Achilles Tendinopathy
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to examine patients with chronic Achilles Tendinopathy (AT) and to
compare the effect of high volume injection (HVI) or autologous conditioned plasma (ACP) in
combination with eccentric training to placebo treatment (sham treatment combined with
eccentric exercises).
Healthy males with AT will be randomly assigned to either 1) HVI (50 mls;10 mls 0.5%
bupivacaine hydrochloride and 20 mg of Depomedrol followed by 40 mls saline), 2) ACP (~ 4
mls) or 3) Placebo (Plc) treatment. All subjects will perform a 12-wk eccentric training
program and examinations will be done at baseline (before treatment) with follow-ups after 6
weeks, 12 weeks and again after 24 weeks prior to baseline to see any possible changes and
differences between groups (HVI, ACP and Plc)